Web Analytics
Ingersoll Rand Inc (IR) (Q2 2026) Earnings Call Highlights: Strong Execution Drives Revenue ... | Deepscope News
MARKET

Select Market Data Region

 August 1, 2026 02:00 AM  finance.yahoo.com Positive

Ingersoll Rand Inc (IR) (Q2 2026) Earnings Call Highlights: Strong Execution Drives Revenue ...

Image

This article first appeared on GuruFocus.

Revenue: Grew 9% year-over-year to approximately $2 billion, with organic revenue growth of 4%. Orders: Finished just over $2 billion, up 5% year-over-year, with organic orders up 2%. Adjusted EBITDA: $520 million, an increase of 2% year-over-year, with an adjusted EBITDA margin of 25.4%. Adjusted EPS: $0.86 for the quarter, up 7% year-over-year. Free Cash Flow: $269 million for the quarter, up roughly 28% year-over-year. Segment - IT Revenue: Increased nearly 9% year-over-year, including organic revenue growth of 4%. Segment - IT Adjusted EBITDA: $435 million, with margins of 26.8%. Segment - PST Orders: Increased 11% year-over-year, including 7% organic growth. Segment - PST Revenue: Increased by 8% year-over-year, including 4% organic growth. Segment - PST Adjusted EBITDA: Increased 15% year-over-year to $135 million, with margins expanding 200 basis points to 31.5%. Full Year Revenue Guidance: Raised to 4.5% to 6.5% growth. Full Year Adjusted EBITDA Guidance: Maintained at $2.13 billion to $2.19 billion. Full Year Adjusted EPS Guidance: Maintained at $3.45 to $3.55, expected to finish near the high end.

Warning! GuruFocus has detected 9 Warning Signs with TROW. Is IR fairly valued? Test your thesis with our free DCF calculator.

Release Date: July 31, 2026

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Positive Points

Ingersoll Rand Inc (NYSE:IR) reported strong second-quarter results with organic order growth of 2%, organic revenue growth of 4%, and adjusted EPS growth of 7%, demonstrating solid execution and demand momentum. The company raised its full-year revenue guidance by 200 basis points at the midpoint, driven by healthy demand and strong first-half performance, particularly in short to medium cycle businesses. Ingersoll Rand Inc (NYSE:IR) announced two strategic acquisitions (Lone Star Blowers and Filtri) that strengthen core technologies and aftermarket capabilities, with a robust M&A pipeline including 11 additional transactions under LOI. The Precision Technologies & Services (PST) segment delivered excellent results with 7% organic order growth, 4% organic revenue growth, and 200 basis points of adjusted EBITDA margin expansion to 31.5%. Ingersoll Rand Inc (NYSE:IR) reported a strong start to July with double-digit organic order growth, driven by the realization of delayed long-cycle projects and continued short-cycle strength, boosting confidence in the second half. The company received a one-notch credit rating upgrade from Moody's to Baa1, reflecting a strong balance sheet with leverage at 1.7x and significant liquidity of $3.8 billion. Free cash flow increased 28% year-over-year to $269 million, and the company secured an initial $187.5 million insurance recovery related to the ILC Dover transaction, providing additional capital allocation firepower.

Story Continues

Negative Points

Adjusted EBITDA margin declined 160 basis points year-over-year to 25.4%, impacted by inflationary pressures in China, continued growth investments, and higher corporate costs. Organic orders in the EMEA region were down low double digits, primarily due to timing delays in long-cycle blower and vacuum projects in Europe and continued project delays in the Middle East. China remains a challenging market from a pricing perspective, where inflationary pressures are difficult to offset with price, impacting margin performance in the ITS segment. The company experienced a year-to-date true-up of management incentive costs in Q2, which increased corporate costs and pressured margins, though not expected to recur at the same level in the back half. Book-to-bill ratio was 1.0x, slightly lower than typical for Q2, reflecting delayed timing of several large project orders, which could impact near-term revenue visibility. Adjusted EBITDA guidance was maintained at $2.13 billion to $2.19 billion, implying a significant margin ramp in the second half that relies on price realization, productivity, and non-recurrence of one-time costs. The company walked away from a potential $1 billion acquisition due to valuation, indicating disciplined capital allocation but also highlighting challenges in finding attractively priced larger deals.

Q & A Highlights

Q: Can you provide more color on the momentum you're seeing in the short and medium cycle business, including regional dynamics and end-market trends?A: Vicente Reynal (Chairman and CEO) noted that the Americas, representing roughly 50% of revenue, is the strongest region with high single-digit order growth and healthy compressor activity. EMEA orders were down low double digits organically due to timing of long-cycle projects and Middle East delays, but core compressor orders were up low single digits. Asia Pacific, with China around 10% of total revenue, saw organic revenue up low double digits, though pricing remains challenged. End-market strength was broad-based, including power gen, electricity infrastructure, air separation for semiconductors, and biopharma, which continues to see low double-digit growth.

Q: Are the longer-cycle project pushouts starting to roll through, and how do you see that activity playing out?A: Vicente Reynal (Chairman and CEO) indicated growing encouragement as customers become more enthusiastic and projects move in a better direction. He highlighted energy efficiency as a key driver, noting that as power prices rise, the payback on replacing older, less efficient compressors shortens. He also mentioned that engineering capacity and EPC constraints that previously caused delays are freeing up.

Q: Can you clarify the July order commentary? Is the double-digit growth organic, and are these long-cycle orders building backlog for 2027?A: Vicente Reynal (Chairman and CEO) confirmed that July organic order growth was low double-digit to mid-teens. Vikram Kini (CFO) added that long-cycle projects, typically with 6- to 18-month durations, are largely building backlog for 2027, though some revenue recognition could occur in the back half of the year. The strong July performance reflects both long-cycle projects reaching the finish line and continued solid short-cycle momentum.

Q: What is driving the stronger-than-typical back-half margin ramp, and how much is price versus other factors?A: Vikram Kini (CFO) broke down the sequential margin expansion into three key drivers: better price realization from actions taken in the first half, normalization of corporate costs (excluding the Q2 incentive compensation true-up), and productivity benefits from direct material and I2V actions that typically materialize more in the back half. He noted that direct material productivity generally follows cost of goods sold, with the strongest finish typically in Q4.

Q: Can you elaborate on the trends in Life Sciences and Precision Technologies, and is the growth durable?A: Vicente Reynal (Chairman and CEO) cited strong momentum in Life Sciences, driven largely by biopharma and continued exposure to GLP-1. He noted investments to play in the larger biopharma side, with potential benefits from new facility investments moving into 2027. Vikram Kini (CFO) added that Precision Technologies has a comparable look and feel to ITS, with solid momentum in shorter-cycle core pump businesses and longer-cycle project activity being worked through similarly.

Q: Would ITS margins have expanded this quarter absent the China headwind, and what is the expectation for full-year margins?A: Vikram Kini (CFO) stated that China was the single biggest driver of margin pressure, and without it, margins would have been much more comparable. For the full year, he expects Q4 exit rates to be in line with or slightly above prior year, though full-year margins may trend slightly below 2025 levels. He reiterated confidence in the ITS business approaching the 30% EBITDA margin profile discussed at Investor Day, viewing China pricing issues as transient.

Q: How would you characterize the M&A environment, and are valuations attractive for larger deals?A: Vicente Reynal (Chairman and CEO) described the M&A environment as very healthy, with a funnel of over 200 companies and 11 transactions under LOI. He noted the company walked away from a potential $1 billion deal due to valuation, demonstrating continued discipline. The announced acquisitions of Lone Star Blowers and Filtri are consistent with the strategy of acquiring market-leading technologies that strengthen the core and expand aftermarket capabilities.

Q: What are you seeing in the pricing environment outside of China, and are there any shifts in market share dynamics?A: Vicente Reynal (Chairman and CEO) stated that pricing outside of China remains stable at the typical 1% to 2% range, with no dramatic changes. He emphasized that the strong order momentum in the Americas is more volume-related than price-driven. The China pricing challenge is categorized as transitory, driven by capacity investments made in prior years, with improving momentum in the region.

Q: How do you see AI and infrastructure investment pertaining to Ingersoll Rand, and where would this materialize?A: Vicente Reynal (Chairman and CEO) highlighted that compressors are needed in power generation and electricity infrastructure, and the company's pumps and blowers play a role in closed-loop water systems for data centers. He noted the company is the market leader in authorizing natural gas for power generation, which falls under the PST segment. These investments are broad-based across multiple end markets, though implementation takes time.

Q: Can you provide your view on PST margins for the second half of the year?A: Vikram Kini (CFO) expects continued sequential momentum in PST margins, with Q2 coming in around 31.5% EBITDA margin. He anticipates the number to be slightly better in the back half, in the 32% range or slightly better, with the mid-30s EBITDA margin target definitely in sight. This reflects strong execution across the portfolio and continued benefits from IRX.

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

View Comments

Read original source